Abstract
INTRODUCTION
Bicuspid aortic valve (BAV) is the most common congenital heart malformation (0.5-2% of live births) and is associated with an increased risk, compared to the general population, of diseases of both the valve and the proximal aorta, including aneurysms. Ascending aorta (AA) dilation has been ascribed both to the haemodynamic consequences of BAV morphology and to the effect of some genetic variants impairing the biomechanical behaviour of the aortic wall. An in-depth knowledge of the pathogenetic bases of BAV aortopathy is still missing, with consequences on its risk prediction and management. A well-designed comparison between AA wall samples from BAV and tricuspid aortic valve (TAV) patients, which are similar in terms of clinical and demographic characteristics, could represent a useful approach for the identification of BAV-specific pathogenetic mechanisms of aortopathy. Several studies have already revealed a variety of differences between BAV-and TAV-associated AA in terms of gene expression [1, 2] , epigenetics [3] , circulating factors [4] , histology [5] , cell senescence and apoptosis [6] and haemodynamics [7] . However, proteomics comparative studies are still limited [8, 9] . Proteome profiling by 2-dimensional gel electrophoresis can provide an overview of the abundant cellular proteins within a tissue, also indicating their potential posttranslational modifications (PTMs). The definition of tissue-specific proteomes, with a particular reference to the vascular tissue, remains a more challenging task than genomics and transcriptomics [10] .
One of the key challenges in aortic aneurysm research is to elucidate factors that initiate aneurysm development. A recent study revealed that the phenotype of a mature aneurysm does not depend on its location and might, thus, represents a common end-stage picture regardless of the etiology of the disease [11] . These observations limit the utility of aortic aneurysm samples in proteomics data mining to elucidate the possibly different, site-specific, initial steps of the aneurysm formation. In this study we compared the cellular proteome in samples of mildly dilated AAs from TAV and BAV patients, undergoing surgery for aortic valve stenosis, aiming to identify the early molecular alterations contributing to or affected by aortopathy. To distinguish between constitutive and flow-induced molecular changes, we focused on 2 regions of each AA from TAV and BAV patients, corresponding to the convexity (CVX) and the concavity (CCV) of its profile, known to be exposed to different haemodynamic stimuli due to the BAV-inherent eccentricity of jet-stream [12] .
MATERIALS AND METHODS

Patient demographics
The study included samples from AAs with diameter <4.5 cm obtained from 52 informed and consenting patients with a severe echocardiographic degree of TAV or BAV stenosis and undergoing valve replacement surgery (Table 1) . Aortic valve stenosis was graded on the basis of the morphological evaluation and Doppler-derived measurements of gradients and velocity. Mild AA dilatation, when present, was limited to the tubular ascending tract (ascending phenotype). Patients with syndromic connective tissue disorders, impaired systolic ventricular function, other cardiac diseases or aortic dissection were excluded. The study was approved by the Ethics Committee of the Università della Campania 'L. Vanvitelli' Naples, Italy and the local Research Ethics Committee for St George's Hospital, and performed in accordance with the Declaration of Helsinki.
Aortic sample collection
At surgery, 2 aortic samples were retrieved from each AA, 1 from the CVX region and 1 from the CCV region, both 1-2 cm distal to the sinotubular junction (from the ends of the transverse aortotomy). The tissue samples (average size: 4 Â 1 mm) were immediately snap frozen and kept in liquid nitrogen for later proteome analysis or stored in RNALater at -80 C for subsequent ribonucleic acid (RNA) extraction or fixed in 4% buffered formaldehyde for subsequent immunofluorescence analysis.
Tissue processing and cellular protein extraction
Aortic tissue from the AA CVX and CCV of TAV (n = 6) and BAV (n = 6) patients were subjected to a solubility-based protein subfractionation methodology aimed at the enrichment of cellular proteins as previously described [13] , through a 0.5 M NaCl treatment (able to displace polyionic interactions among proteins, thus enabling the extraction of loosely bound extra-cellular matrix (ECM) proteins), followed by decellularization with 0.08% sodium dodecyl sulphate. The protein concentration was estimated by UV absorbance. The average concentration of proteins extracted from aortic samples was not statistically different between BAV and TAV patients and between aortic regions, ranging from 0.59 to 3.33 lg/ll.
Cellular proteome analysis
Cellular proteins from BAV and TAV AA samples were compared through 2-dimensional fluorescence difference in-gel electrophoresis (2D-DIGE). The sodium dodecyl sulphate extracts of each sample were cleaned using 2D Clean-up Kit (BioRad). Cellular protein extracts from aortic CVX or CCV, to be directly compared, were labelled with Cy3 and Cy5 fluorescent tag (GE Healthcare) and coseparated together with Cy2-labelled internal pooled standard on immobilized pH gradient strips (18 cm, pH 3-10 non-linear, GE Healthcare) followed by sodium dodecyl sulphatepolyacrylamide gel electrophoresis on large format 12% gels. Images were acquired on a fluorescence scanner and gels were counterstained with silver. DeCyder V R software v7.0 was used for spot detection, spot matching, quantification and statistical analyses. Protein spots with a fold change >1.2 or <-1.2 in CVX or CCV of AA samples from BAV versus TAV patients and a P-value <0.05 were considered to be significantly differentially regulated ( Fig. 1 ) and were manually picked from the gels, digested with trypsin and identified by liquid chromatography-tandem mass spectrometry (MS/MS). The peptides were separated using nanoflow HPLC (Ultimate 3000 RSLCnano, PepMap C18 column, 75 mm Â 25 cm, Thermo Fisher Scientific) and directly analysed by LTQ Orbitrap XL (Thermo Fisher Scientific). Full MS scans were collected using the Orbitrap over m/z range of 400-1600. MS/MS were performed on the top 6 ions in each full MS scan using the data-dependent acquisition with dynamic exclusion enabled. Mascot 2.3.01 was used for matching to a human database (UniProtKB/ Swiss-Prot 2013_05, 20256 protein entries) of the MS/MS peak lists generated [13] . Cysteine carbamidomethylation and methionine oxidation were chosen as fixed and variable modifications, respectively. Search results were loaded into Scaffold 4.0.6 and protein identifications were accepted if established at a probability >99.0% with at least 2 independent peptides.
The Protein Analysis through Evolutionary Relationships Classification System (Version 11) and its associated tools [14] were used for the Gene Ontology (GO) classification and for the biological pathway statistical over-representation test of proteins differentially regulated in BAV versus TAV AA samples, using as reference the Reactome pathway database (Version 64). The Fisher's exact test detected an overlap between the differentially regulated protein list and the GO annotation list beyond expected by chance. P-values < _0.05 denoted the statistical significance of the GO term and the pathway enrichment among differentially regulated proteins in BAV versus TAV AA samples. The STRING database (Version 10.5) was used for an analysis of interactions among proteins differentially expressed between BAVand TAV-associated AAs.
RNA extraction and reverse transcriptionpolymerase chain reaction analysis
Total RNA was extracted from whole aortic samples (n = 16 TAV and 16 BAV) using the RNAeasy minikit (Qiagen), including a DNase treatment. The RNA concentration was measured with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific) and its integrity was verified by electrophoresis on denaturing 1% agarose gel. The absence of residual DNA was verified by polymerase chain reaction (PCR) on total RNA without reverse transcription (RT). GeneBank V R sequences for human mRNAs and OligoArchitect TM (Merck) were used to design primer pairs for the target genes (Supplementary Material, Table S1 ). RT-PCR experiments were performed as previously described [1] . RT-PCR expression data for target genes were normalized against the expression of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase, independent from valve morphology, aortic diameter, gender and age [15] .
Immunofluorescence analysis
Aortic samples from TAV (n = 4) and BAV (n = 4) patients were fixed in 4% buffered formaldehyde, dehydrated and embedded in paraffin. Consecutively, 5-lm cross-sections were deparaffinized and rehydrated. Antigen retrieval was done in the microwave with 10 mM citrate buffer pH 6. Endogenous peroxidases were blocked with 4% H 2 O 2 . Blocking in 5% donkey serum (Jackson ImmunoResearch) was followed by incubation with the primary mouse monoclonal antibody for smooth muscle actin (ACTA2) (Merck, clone 1A4, dil. 1:200), detected by a fluorescent TRITClabelled secondary antibody (Jackson ImmunoResearch). Nuclei were counterstained with Hoechst 33258 (Merck), and the Leica 4000F software was used for image screening and photography. 
Statistics and data analysis
A statistical analysis of clinical, demographic and RT-PCR data was carried out using the GraphPad Prism software (GraphPad, San Diego, CA, USA). The comparison between BAV and TAV groups of samples for the differential proteome analysis was performed automatically by the DeCyder software. The Student's t-test was used for normally distributed data, as the assumption of independence of observations was respected here. Differences were considered significant where P-value <0.05. Normally distributed data are presented as mean ± standard deviation.
RESULTS
Bicuspid aortic valve ascending aorta is characterized by a lower expression of specific groups of intracellular proteins versus tricuspid aortic valve ascending aorta
The difference in-gel electrophoresis of aortic tissue lysates (n = 6 patients per group; age: TAV 68 ± 2 vs BAV 66 ± 4, P = 0.44; diameter: TAV 36 ± 5 vs BAV 38 ± 4, P = 0.37) led to the identification of 52 protein spots differentially expressed in BAV versus TAV AA CVX and 10 spots in BAV versus TAV AA CCV (Fig. 1) . The spot analysis by liquid chromatography-MS/MS led to the identification of 35 differentially regulated proteins in BAV versus TAV aortic CVX and 10 in CCV (Supplementary Material, Table  S2 ). Of note, 37 out of the 52 differentially regulated protein spots showed a decrease in BAV versus TAV CVX; 4 out of the 10 differentially expressed protein spots showed a decrease in BAV versus TAV CCV (Supplementary Material, Table S2 ).
The presence of individual proteins in multiple differentially regulated spots in BAV versus TAV AA samples [e.g. protein disulphide-isomerase A3 (PDIA3), dihydropyrimidinase-related protein 3 (DPYL3), serum amyloid P-component (APCS), annexin A1 (ANXA1) and A2 (ANXA2)] (Supplementary Material, Table S2 ) suggests the presence of potential PTMs (e.g. different phosphorylation states), as supported by matching of their observed to the theoretical molecular weight and isoelectric point.
As expected, the majority of the proteins we identified as differentially regulated in AA samples from BAV and TAV patients were of cellular origin, with a few exceptions, including extracellular superoxide dismutase (SOD3, spot 37 in Fig. 1 , significantly Alternative techniques confirmed differences in 2-dimensional fluorescence in-gel electrophoresis data
The differential expression of proteins ACTA2, SOD3, DPYL3 and protein S100-A9 was further investigated by RT-PCR and immunofluorescence in separate samples from BAV and TAV stenosis patients. The 4 molecular targets we investigated were selected on the basis of their potential role in aortopathy, on the basis of the magnitude of their expression fold change and of the aortic region affected by the change. The RT-PCR analysis confirmed the 2D-DIGE results at the transcriptional level ( Fig. 2A , C and D), with the exception of DPYL3 (Fig. 2B ), possibly suggesting a post-translational regulation of this protein. Of note, the mRNA coding for the protein S100-A9 was detectable only in 37% of aortic samples from TAV patients, whereas it was detectable in 100% of aortic samples from BAV patients, further supporting the different abundance of this protein observed comparing TAV and BAV aortic samples ( Fig. 2A) . Both RT-PCR and immunofluorescence confirmed the increased expression of ACTA2 in BAV versus TAV CVX revealed by 2D-DIGE, and in particular in the central area of the medial layer ( Fig. 2E and F) .
In silico analysis of proteomics data suggested pathogenetic biological pathways Differentially regulated proteins found in BAV versus TAV AA (Supplementary Material, Table S2 ) were classified in domains according to GO definitions (Tables 2 and 3 for aortic CVX and CCV, respectively). Among others, GO classification of the biological functions played by differentially expressed proteins in BAV versus TAV CVX included the protein folding in the endoplasmic reticulum (ER) (P = 2.57e-06), the regulation of apoptotic signalling pathway (P = 1.56e-07) and the actin filament-based process (P = 1.53e-05) ( Table 2) .
Twenty-four biological pathways were identified through Protein Analysis through Evolutionary Relationships analysis as the most significantly enriched among up-and down-regulated proteins or down-regulated proteins only in BAV versus TAV CVX (P < 0.05, false discovery rate < 0.05) ( Table 4 ). Protein changes in BAV versus TAV CVX affected mostly the smooth muscle contraction, the haemostasis (e.g. platelet degranulation, platelet activation, signalling and aggregation), the signal transduction (e.g. RHO GTPases activate protein kinases N), the metabolism (e.g. gluconeogenesis, glycolysis, reversible hydration of CO 2 ) and the cell cycle pathways [e.g. Chk1/Chk2 (Cds1) mediated inactivation of the cyclin B: Cdk1 complex] (Table 4 ). An analogous pathway enrichment analysis performed exclusively on up-regulated proteins in BAV versus TAV CVX showed that only 3 pathways were significantly enriched, exclusively for the concomitant upregulation of carbonic anhydrase 1 (CAH1) and 2 (CAH2) (Supplementary Material, Table S5 , pathways in bold).
The STRING-generated network among proteins differentially regulated in BAV versus TAV aortic CVX exhibited more interactions than expected (P < 1.0e-16) (Fig. 3) Probably related to the limited number of differentially regulated proteins between BAV and TAV at the CCV site, no significant results were obtained from their in silico analysis.
DISCUSSION
Our cellular proteomics data adds to the current knowledge on the pathogenesis of BAV aortopathy and pave the way for future in-depth studies. The asymmetric spatial distribution of protein changes, with a decreased expression specifically in BAV versus TAV aortic CVX of well-defined groups of proteins (including those involved in smooth muscle cell contractile phenotype, metabolism and mammalian cell stress), is a hallmark of early BAV aortopathy and suggests a role for BAV-associated flow abnormalities in the development of the ascending phenotype dilatations found in a proportion of BAV patients. This finding is consistent with our previous studies [1, 4] and with computational studies indicating the existence of strong haemodynamic abnormalities also in non-dilated BAV AAs, and their colocalization with the sites most vulnerable to dilation, namely the CVX wall [16] . These flow abnormalities in BAV patients can impact the vascular wall through the endothelium, which is able to sense and respond to changes in wall shear stress magnitude, directionality and frequency through the expression of cytokines, modulation of ion channels and activation of SMC signalling [1, 4] . Aortic valve stenosis and regurgitation are associated with distinct alterations of the aortic wall [17] : we overcame this potential confounding factor by enrolling only patients similar in terms of valve dysfunction, i.e. with high-grade stenotic BAV/TAV, thus differentiating our study from others [18] . Similarly, we did not include all stages of aortopathy but selected patients with mild dilatation (diameter <45 mm), to obtain a homogeneous population of samples representative of the early phases of the disease.
The presence of potential PTMs for a subset of differentially expressed proteins in BAV versus TAV aortic samples (e.g. 6 different phosphorylation states for DPYL3, as resulting from the matching between the putative and experimental pI/MW of its 6 spots in 2D-DIGE, Fig. 1, Supplementary Material, Table S2 ), could modify the protein charge and, possibly, their biological activity, consistent with the current literature [9] .
Among the present results, the reduced expression of the potent antioxidant enzyme SOD3 in BAV versus TAV CCV may suggest a constitutively more altered redox balance and a deficiency in antioxidant defence in BAV versus TAV patients, consistent with the current literature [4, 19] . Of interest, our data suggest a higher mammalian stress response in TAV versus BAV CVX samples, with a higher expression of glucose-regulated protein 78 (GRP78), heat shock protein beta-1 (HSPB1, alias HSP27), endoplasmin (ENPL, alias HSP90B1/GRP94) and CLU (alias apolipoprotein J). This was also supported by the statistical significance of the stress-related biological pathways and GO categories where they were classified (Tables 2 and 4 ); in particular, GRP78 and Fold enrichment, FDR and P-values are reported for each subcategory in all GO domains (P < 0.05; FDR < 0.05).
AA: ascending aorta; ATF6: activating transcription factor-6; BAV: bicuspid aortic valve; CVX: convexity; FDR: false discovery rate; GO: Gene Ontology; mRNA: messenger ribonucleic acid; TAV: tricuspid aortic valve.
ENPL are resident in the ER, where they act as chaperones for folding of unfolded proteins [20] . A detrimental role for ER stress in the induction of endothelial dysfunction, inflammation, cell death and consequently, in aortic aneurysm has already been reported in murine models [21] . A hypothesis to be tested, arising from the present results, is that the CVX wall of BAV AA may undergo inhibition, by flow-related aberrant stimuli, of protective mechanisms against ER stress. ER stress has not been thoroughly investigated so far in BAV aortopathy and warrants additional studies. The chaperone protein HSPB1 has been reported to show 4 different phosphorylation states in AA from BAV/TAV patients [9] , consistent with the presence of HSBP1 in multiple spots with an increasing pI in this study (Supplementary Material, Table S2 ). The role of the different HSPB1 phosphorylation states in BAV aortopathy remains to be determined. To the best of our knowledge, several proteins included in our findings (e.g. insulin-like growth factor-binding protein 7 [IGFBP7], ANXA2, DPYL3, CAH1 and CAH2) have not been associated with aortopathy so far, and, by virtue of their biological functions, their potential role in this setting should be investigated. Among them, CAH1 and CAH2 (higher in BAV versus TAV CVX) are able to catalyse the reversible conversion of CO 2 into bicarbonate and play a role in pH regulation [22] . In abdominal aneurysms, CAH1 has been identified as potential autoantigen, possibly for the emergence of distinct epitope(s), most likely brought by different PTMs [23] .
The increased expression of ACTA2 in BAV versus TAV CVX, together with the decreased expression of markers of SMC contractile phenotype (myosin regulatory light polypeptide 9, TAGL and TAGL2), confirms the suggestion of a greater SMC switch from a contractile to a secretory/proliferative phenotype and the concomitant emergence of myofibroblasts in BAV patients, in line with previous studies [1] . Myofibroblasts are specialized cells arising in pathophysiological conditions, contributing to tissue repair and remodelling and sharing the expression of ACTA2 with SMCs. The lower expression of TAGL and TAGL2, already identified as differentially expressed in dilated and non-dilated AAs [8] , together with the observed prelamin-A/C down-regulation, could Figure 3 : STRING protein-protein interaction analysis performed on differentially expressed proteins in bicuspid aortic valve versus tricuspid aortic valve convexity. Network nodes represent proteins; edges represent protein-protein associations. The protein network has significantly more interactions than expected (number of nodes: 34; number of edges: 65; expected number of edges: 16; protein-protein interaction enrichment P-value <1.0e-16). Node and edge colours vary as indicated in the figure legend. ACTA2: smooth muscle actin; APCS: serum amyloid P-component; APOE: apolipoprotein E; ANXA1: annexin A1; ANXA2: annexin A2; ATP5B: adenosine triphosphate synthase F1 subunit beta; BLVRB: Biliverdin reductase B; CA2: carbonic anhydrase 2; CLU: clusterin; DES: desmin; DPYL3: dihydropyrimidinaserelated protein 3; ENO1: enolase 1; ENO2: enolase 2; GRHPR: glyoxylate and hydroxypyruvate reductase; HSPA5: heat shock protein family A; HSPB1: heat shock protein beta-1; IGFBP7: insulin-like growth factor-binding protein 7; LMCD1: LIM and cysteine rich domain 1; LMNA: lamin A/C; MFAP4: microfibril associated protein 4; MYL9: myosin regulatory light polypeptide 9; OGN: osteoglycin; PDIA3: protein disulphide-isomerase A3; PGAM1: phosphoglycerate mutase 1; TAGLN: transgelin; VIM: vimentin; WDR1: WD repeat-containing protein 1; YWHAB: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta; YWHAZ: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta.
also support the hypothesis of a defective maturation or of premature ageing of SMCs in BAV versus TAV aortic CVX [24] .
Limitations
Samples were collected from the aortic CVX and CCV of patients with TAV and BAV early-stage dilatations. In contrast to previous studies [1, 3, 4, 17, 25] that started from the hypothesis of morphological and/or molecular differences between the aortic wall areas with higher and lower shear stress, this study rather focused on the differences between BAV-and TAV-associated aortopathy. Thus, the main finding is represented by the identified differentially regulated pathways between BAV and TAV aorta at the early stage of dilatation. However, the finding of more BAV-versus-TAV differences in terms of proteome at the CVX (paradigm of high shear stress areas in BAV [12, 25] ) indirectly confirmed a role of flow-related forces. The findings of this study require validation in larger cohorts. Hundreds of statistical comparisons were performed by the DeCyder software: the reported differences achieved a nominal statistical significance and the results, unless further confirmed, have to be considered exploratory. Also, the proteomics approach is biased towards abundant cellular proteins. In addition, despite the putative pI/MWs of charge trains for several differentially regulated proteins (e.g. PDIA3, DPYL3, ANXA1, ANXA2) are consistent with their known PTMs, additional investigations will be necessary, as protein degradation or technical artefacts could potentially generate protein charge trains as well [26] .
CONCLUSIONS
The main message of this study is that at the proteome level, differences exist between mild aortic dilatation in BAV and TAV patients and some differentially regulated proteins and overrepresented pathways might also be an important target of further research at other levels. Moreover, greater differences at CVX confirm that the ascending phenotype form of BAV aortopathy is influenced, if not driven, by shear stress abnormalities. The ER stress response and the antioxidant response pathways may be possible targets for further in-depth pathogenetic investigations.
